UG Healthcare eyes emerging markets
The company expects sales from China, Brazil and Nigeria to increase over the next few years
INCREASED risks of transmission from infectious diseases over the years, such as Aids and the avian flu, have raised hygiene awareness in emerging countries such as China, Brazil and Nigeria, and have translated into higher demand for medical supplies, including medical gloves.
But maker of latex and nitrile (synthetic rubber) gloves, Malaysia-based UG Healthcare, expects demand from these markets to surge even further.
With UG Healthcare's products currently distributed to more than 50 countries, including its core markets in the United States and Europe, sales from China, Brazil and Nigeria presently constitutes a small percentage of the company's total revenues for the year ended June 30, 2014, which stood at S$49 million.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Moderna beats quarterly estimates as cost-cutting pares losses
Weight-loss drugmaker Novo Nordisk's profits soar further
Hugo Boss profit tops expectations, but China lags
DBS customers unable to login to Digibank, PayLah! on Thursday
If inflation continues to build, the Fed won’t be able to maintain neutral stance for long